215 related articles for article (PubMed ID: 17962192)
41. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
[TBL] [Abstract][Full Text] [Related]
42. Carboxyl terminus of HSC70-interacting protein (CHIP) down-regulates NF-κB-inducing kinase (NIK) and suppresses NIK-induced liver injury.
Jiang B; Shen H; Chen Z; Yin L; Zan L; Rui L
J Biol Chem; 2015 May; 290(18):11704-14. PubMed ID: 25792747
[TBL] [Abstract][Full Text] [Related]
43. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines.
Dohda T; Maljukova A; Liu L; Heyman M; Grandér D; Brodin D; Sangfelt O; Lendahl U
Exp Cell Res; 2007 Aug; 313(14):3141-52. PubMed ID: 17560996
[TBL] [Abstract][Full Text] [Related]
44. The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development.
Wilson NK; Miranda-Saavedra D; Kinston S; Bonadies N; Foster SD; Calero-Nieto F; Dawson MA; Donaldson IJ; Dumon S; Frampton J; Janky R; Sun XH; Teichmann SA; Bannister AJ; Göttgens B
Blood; 2009 May; 113(22):5456-65. PubMed ID: 19346495
[TBL] [Abstract][Full Text] [Related]
45. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor.
Huang S; Brandt SJ
Mol Cell Biol; 2000 Mar; 20(6):2248-59. PubMed ID: 10688671
[TBL] [Abstract][Full Text] [Related]
46. The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation.
Ahmed SF; Deb S; Paul I; Chatterjee A; Mandal T; Chatterjee U; Ghosh MK
J Biol Chem; 2012 May; 287(19):15996-6006. PubMed ID: 22427670
[TBL] [Abstract][Full Text] [Related]
47. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms of c-myc degradation by nickel compounds and hypoxia.
Li Q; Kluz T; Sun H; Costa M
PLoS One; 2009 Dec; 4(12):e8531. PubMed ID: 20046830
[TBL] [Abstract][Full Text] [Related]
49. Cross talk between expression of the human T-cell leukemia virus type 1 Tax transactivator and the oncogenic bHLH transcription factor TAL1.
Terme JM; Wencker M; Favre-Bonvin A; Bex F; Gazzolo L; Duc Dodon M; Jalinot P
J Virol; 2008 Aug; 82(16):7913-22. PubMed ID: 18495761
[TBL] [Abstract][Full Text] [Related]
50. The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system.
Chen G; Wang Y; Garate M; Zhou J; Li G
Oncogene; 2010 Mar; 29(10):1498-508. PubMed ID: 19935701
[TBL] [Abstract][Full Text] [Related]
51. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype.
Chan WY; Follows GA; Lacaud G; Pimanda JE; Landry JR; Kinston S; Knezevic K; Piltz S; Donaldson IJ; Gambardella L; Sablitzky F; Green AR; Kouskoff V; Göttgens B
Blood; 2007 Mar; 109(5):1908-16. PubMed ID: 17053063
[TBL] [Abstract][Full Text] [Related]
52. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.
Wang F; Chan CH; Chen K; Guan X; Lin HK; Tong Q
Oncogene; 2012 Mar; 31(12):1546-57. PubMed ID: 21841822
[TBL] [Abstract][Full Text] [Related]
53. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
[TBL] [Abstract][Full Text] [Related]
54. SCL and associated proteins distinguish active from repressive GATA transcription factor complexes.
Tripic T; Deng W; Cheng Y; Zhang Y; Vakoc CR; Gregory GD; Hardison RC; Blobel GA
Blood; 2009 Mar; 113(10):2191-201. PubMed ID: 19011221
[TBL] [Abstract][Full Text] [Related]
55. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
[TBL] [Abstract][Full Text] [Related]
56. Scl regulates the quiescence and the long-term competence of hematopoietic stem cells.
Lacombe J; Herblot S; Rojas-Sutterlin S; Haman A; Barakat S; Iscove NN; Sauvageau G; Hoang T
Blood; 2010 Jan; 115(4):792-803. PubMed ID: 19850742
[TBL] [Abstract][Full Text] [Related]
57. Target-dependent effect of phosphorylation on the DNA binding activity of the TAL1/SCL oncoprotein.
Prasad KS; Brandt SJ
J Biol Chem; 1997 Apr; 272(17):11457-62. PubMed ID: 9111058
[TBL] [Abstract][Full Text] [Related]
58. Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts.
Tang T; Prasad KS; Koury MJ; Brandt SJ
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):615-20. PubMed ID: 10527940
[TBL] [Abstract][Full Text] [Related]
59. A novel mode of enhancer evolution: the Tal1 stem cell enhancer recruited a MIR element to specifically boost its activity.
Smith AM; Sanchez MJ; Follows GA; Kinston S; Donaldson IJ; Green AR; Göttgens B
Genome Res; 2008 Sep; 18(9):1422-32. PubMed ID: 18687876
[TBL] [Abstract][Full Text] [Related]
60. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
Hsu HL; Wadman I; Baer R
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3181-5. PubMed ID: 8159721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]